Prot #BAY 94-8862/16243: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY-94-8862 in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropa